← FDA Drug Approvals (Drugs@FDA)

ICATIBANT ACETATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2020-06-18

Drug application

FDA Application #

ANDA208317

Application type

Abbreviated New Drug Application (Generic)

Brand name

ICATIBANT ACETATE

Generic name

ICATIBANT

Active ingredients

ICATIBANT ACETATE

Dosage form

INJECTABLE

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

FRESENIUS KABI USA

Manufacturer

Fresenius Kabi USA, LLC

First approval

2020-06-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown